Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C48H73ClN2O6 |
| Molecular Weight | 809.556 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 9 / 9 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1=C2[C@H]3CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@]2(CC1=O)[C@@H](O)CN(CCN(C)C)CC6=CC=C(Cl)C=C6
InChI
InChIKey=MEOWKUXNVNJAMY-PZFKGGKESA-N
InChI=1S/C48H73ClN2O6/c1-30(2)40-34(52)26-48(37(53)29-51(25-24-50(10)11)28-31-12-14-32(49)15-13-31)23-22-46(8)33(41(40)48)16-17-36-45(7)20-19-38(57-39(54)27-43(3,4)42(55)56)44(5,6)35(45)18-21-47(36,46)9/h12-15,30,33,35-38,53H,16-29H2,1-11H3,(H,55,56)/t33-,35+,36-,37+,38+,45+,46-,47-,48+/m1/s1
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0019075 Sources: https://www.ncbi.nlm.nih.gov/pubmed/29930812 |
|||
Target ID: CHEMBL247 Sources: https://patents.google.com/patent/WO2013090664A1 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1443460-91-0
Created by
admin on Mon Mar 31 21:49:50 GMT 2025 , Edited by admin on Mon Mar 31 21:49:50 GMT 2025
|
PRIMARY | |||
|
G9C7884M8M
Created by
admin on Mon Mar 31 21:49:50 GMT 2025 , Edited by admin on Mon Mar 31 21:49:50 GMT 2025
|
PRIMARY | |||
|
GSK-2838232
Created by
admin on Mon Mar 31 21:49:50 GMT 2025 , Edited by admin on Mon Mar 31 21:49:50 GMT 2025
|
PRIMARY | Biological Activity of GSK2838232: GSK2838232 inhibits HIV reverse transcriptase activity across a broad panel of HIV-1 isolates, extracted from patent WO/2013090664A1, compound 51. | ||
|
71580991
Created by
admin on Mon Mar 31 21:49:50 GMT 2025 , Edited by admin on Mon Mar 31 21:49:50 GMT 2025
|
PRIMARY |
ACTIVE MOIETY